ClinicalTrials.Veeva

Menu

Bone Mass Changes in Anorexia Nervosa Patient Followed During 4 Years (AMOS)

U

University Hospital, Lille

Status

Completed

Conditions

Osteoporosis
Anorexia Nervosa

Treatments

Device: DEXA

Study type

Observational

Funder types

Other

Identifiers

NCT02891356
2011_38
2012-A01009-34 (Other Identifier)

Details and patient eligibility

About

The mechanism of bone loss in anorexia nervosa is complex. Marrow adipose tissue seems to play a role in the regulation of bone metabolism. Adipocytes secrete cytokines and adipokines that either stimulate or inhibit adjacent osteoblasts. This study consist to explore the relationship in anorexia nervosa patients with change in bone mineral density and adipokines like leptin, adiponectin and Préf-1 Bone mineral densities will be measure in 180 anorexia nervosa patients at inclusion and every two years during 6 years.It is assessed blood and urinary calcium and phosphate levels, bone remodelling markers and adipokines (leptin, adiponectin and Préf-1)

Enrollment

180 patients

Sex

Female

Ages

18 to 35 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • anorexia patient defined by DSM IV diagnostic criteria

Exclusion criteria

  • patient with other psychiatric disease
  • patient with other a metabolic bone disease

Trial design

180 participants in 1 patient group

Anorexia patient
Description:
Dual Energy X-ray Absorptiometry (DEXA)
Treatment:
Device: DEXA

Trial contacts and locations

1

Loading...

Central trial contact

Isabelle LEGROUX, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems